These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12614183)

  • 1. Pharmacoeconomics of asthma treatment.
    Cleland J; Thomas M; Price D
    Expert Opin Pharmacother; 2003 Mar; 4(3):311-8. PubMed ID: 12614183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Database studies in asthma pharmacoeconomics: uses, limitations and quality markers.
    Thomas M; Cleland J; Price D
    Expert Opin Pharmacother; 2003 Mar; 4(3):351-8. PubMed ID: 12614187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacoeconomics of asthma].
    Jahnz-Rózyk K; Targowski T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():48-9. PubMed ID: 15524016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of asthma therapy: a comprehensive review.
    Domínguez-Ortega J; Phillips-Anglés E; Barranco P; Quirce S
    J Asthma; 2015; 52(6):529-37. PubMed ID: 25539023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic Cost of Asthma and Psychiatric Morbidity in Nigerian Patients with Asthma.
    Oloniniyi IO; Aloba OO; Akinsulore A; Adeniyi BO; Oginni OA; Erhabor GE; Makanjuola RO
    West Afr J Med; 2019; 36(3):267-273. PubMed ID: 31622490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost, morbidity, and control of asthma in Hungary: The Hunair Study.
    Herjavecz I; Nagy GB; Gyurkovits K; Magyar P; Dobos K; Nagy L; Alemao E; Ben-Joseph R
    J Asthma; 2003 Sep; 40(6):673-81. PubMed ID: 14579999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost of Asthma Treatment in Phramongkutlao Hospital: Population-Based Study in Adults.
    Boonpiyathad T; Yimsawad S; Sangasapaviriya A
    J Med Assoc Thai; 2016 Jan; 99(1):51-7. PubMed ID: 27455824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaching value in asthma management: the need to integrate clinical and economic research with the basic science.
    Stempel DA; Kelly HW
    J Allergy Clin Immunol; 2002 May; 109(5 Suppl):S503-10. PubMed ID: 11994722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cost of asthma therapy in relation to severity. An empirical study].
    Graf von der Schulenburg JM; Greiner W; Molitor S; Kielhorn A
    Med Klin (Munich); 1996 Oct; 91(10):670-6. PubMed ID: 9019647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of asthma practices.
    Stempel DA
    Am J Manag Care; 2000 Oct; 6(17 Suppl):S930-6; discussion S937-9. PubMed ID: 11184564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medication adherence in asthma therapy--a structured review].
    Fischer J; Wimmer A; Mahlich J
    Pneumologie; 2013 Jul; 67(7):406-14. PubMed ID: 23797492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of asthma treatment in Spain and rationalizing the expense.
    Nieto A; Alvarez-Cuesta E; Boquete M; Mazón A; de la Torre F
    J Investig Allergol Clin Immunol; 2001; 11(3):139-48. PubMed ID: 11831444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic cost of treating the patient with asthma in Spain: the AsmaCost study].
    Martínez-Moragón E; Serra-Batllés J; De Diego A; Palop M; Casan P; Rubio-Terrés C; Pellicer C;
    Arch Bronconeumol; 2009 Oct; 45(10):481-6. PubMed ID: 19525051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between pharmaceutical costs, disease severity, and health-related quality of life in asthmatics in Swedish primary care.
    Arnlind MH; Nokela M; Rehnberg C; Jonsson EW
    J Asthma; 2006 Oct; 43(8):585-91. PubMed ID: 17050222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.
    Vennera Mdel C; Valero A; Uría E; Forné C; Picado C
    Clin Drug Investig; 2016 Jul; 36(7):567-78. PubMed ID: 27142072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budget impact analysis of a fixed-dose combination of fluticasone propionate and formoterol fumarate (FP/FORM) in a pressurized metered-dose inhaler (pMDI) for asthma.
    Dunlop W; Heron L; Fox G; Greaney M
    Adv Ther; 2013 Oct; 30(10):933-44. PubMed ID: 24194361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomics of Bronchial Asthma.
    Ivanova ZI; Ivanov YY
    Folia Med (Plovdiv); 2019 Jun; 61(2):163-171. PubMed ID: 31301669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial.
    Baxter-Jones AD; Helms PJ; Russell G; Grant A; Ross S; Cairns JA; Ritchie L; Taylor R; Reid DM; Osman LM; Robins S; Fletcher ME
    Health Technol Assess; 2000; 4(28):1-89. PubMed ID: 11074396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
    Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK;
    J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.